MedTrace Logo

Relation Between Lab Finding and COVID-19 Severity

NCT04470557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-07-14

No results posted yet for this study

Summary

Severe acute respiratory syndrome coronavirus 2 (COVID-19) poses substantial challenges for health care systems. With a vastly expanding amount of publications on COVID-19, clinicians need evidence synthesis to produce guidance for handling patients with COVID-19.

Conditions

Interventions

DIAGNOSTIC_TEST

D-dimer,CBC.ESR,CRP,

Complete blood count (for patients and control subjects): was done on CELL-DYN 3700 (Abbott-Germany) and blood film was stained by leishman staining, the morphology of red blood cells. CRP titre estimation by latix method .ESR erythrocyte sedimentation rate estimation (1:5) by Westerngreen tube method.

DIAGNOSTIC_TEST

Liver function tests ,serum ferritin and PCR for COVID-19 .

Serum ferritin was performed for all subjects on Modular P auto analyzer (Roche Diagnostics, Mannheim, Germany), • Liver function tests ( aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase) and kidney funcrion were performed for all subjects on Modular P auto analyzer (Roche Diagnostics, Mannheim, G ermany),

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Esam_eldeen M. Abdalla, Doctorate · Assiut University

  • Heba Abdellatif, Doctorate · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2020-10-01
Completion
2020-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04470557 on ClinicalTrials.gov